144 related articles for article (PubMed ID: 10892724)
1. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver.
Steiner S; Gatlin CL; Lennon JJ; McGrath AM; Aponte AM; Makusky AJ; Rohrs MC; Anderson NL
Electrophoresis; 2000 Jun; 21(11):2129-37. PubMed ID: 10892724
[TBL] [Abstract][Full Text] [Related]
2. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin.
Steiner S; Gatlin CL; Lennon JJ; McGrath AM; Seonarain MD; Makusky AJ; Aponte AM; Esquer-Blasco R; Anderson NL
Toxicol Lett; 2001 Mar; 120(1-3):369-77. PubMed ID: 11323196
[TBL] [Abstract][Full Text] [Related]
5. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.
Lopez D; Chambers CM; Ness GC
Arch Biochem Biophys; 1997 Jul; 343(1):118-22. PubMed ID: 9210653
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
7. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
[TBL] [Abstract][Full Text] [Related]
9. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet.
Sandhya VG; Rajamohan T
Food Chem Toxicol; 2008 Dec; 46(12):3586-92. PubMed ID: 18809454
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles.
Ortiz PA; Bruno ME; Moore T; Nesnow S; Winnik W; Ge Y
J Proteome Res; 2010 Mar; 9(3):1268-78. PubMed ID: 20095644
[TBL] [Abstract][Full Text] [Related]
13. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation.
Björkhem-Bergman L; Acimovic J; Torndal UB; Parini P; Eriksson LC
Anticancer Res; 2010 Apr; 30(4):1105-12. PubMed ID: 20530415
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis of fatty liver in feed-deprived dairy cows reveals interaction of fuel sensing, calcium, fatty acid, and glycogen metabolism.
Kuhla B; Albrecht D; Kuhla S; Metges CC
Physiol Genomics; 2009 Apr; 37(2):88-98. PubMed ID: 19240300
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol biosynthesis and the pro-apoptotic effects of the p75 nerve growth factor receptor in PC12 pheochromocytoma cells.
Yan C; Mirnics ZK; Portugal CF; Liang Y; Nylander KD; Rudzinski M; Zaccaro C; Saragovi HU; Schor NF
Brain Res Mol Brain Res; 2005 Oct; 139(2):225-34. PubMed ID: 15967538
[TBL] [Abstract][Full Text] [Related]
17. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
18. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
19. Induction of macrophage elastase (MMP-12) gene expression by statins.
Arikan MC; Shapiro SD; Mariani TJ
J Cell Physiol; 2005 Jul; 204(1):139-45. PubMed ID: 15605420
[TBL] [Abstract][Full Text] [Related]
20. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
